We next carried out microarray studies to identify at the whole transcriptome level the hypoxia and G9A target genes that could account for the phenotypic effects on cancer function and may be candidates for cancer treatment, especially in the context of hypoxic tumors. The gene discussed is EHMT2; the disease is cancer.